Fintel reports that on March 30, 2026, Jefferies initiated coverage of Vor Biopharma (NasdaqGS:VOR) with a Buy recommendation. Analyst Price Forecast Suggests 163.65% Upside As of March 27, 2026, the ...
First patient dosed in UPSTREAM SjD, a global Phase 3 clinical trial assessing telitacicept in primary Sjögren’s disease $75 million private placement strengthens balance sheet and supports ...
A new study finds that certain patterns of AI use are driving cognitive fatigue, while others can help reduce burnout. by Julie Bedard, Matthew Kropp, Megan Hsu, Olivia T. Karaman, Jason Hawes and ...
Corrected: A previous version of this story should have said that the Pew Research Center conducted the survey. There’s fear among many educators that most students are now using AI to do too much of ...
People who interact with chatbots for emotional support or other personal reasons are likelier to report symptoms of depression or anxiety, a new study finds. Subscribe to read this story ad-free Get ...
Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. After ...
Vor Biopharma Inc. (VOR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
Man laying on bed at late night in a dark room checking his smartphone. Internet addiction. Man laying on bed at late night in a dark room checking his smartphone. Internet addiction.Moment ...
When you're flying on a commercial jet and going through a cloud, it's easy to wonder how pilots know where they're going, but through an assortment of tools and instruments -- like a VHF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results